Wang Y - Search Results

1

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.

Lu Z, Wang J, Shu Y, Liu L, Kong L, Yang L, Wang B, Sun G, Ji Y, Cao G, Liu H, Cui T, Li N, Qiu W, Li G, Hou X, Luo H, Xue L, Zhang Y, Yue W, Liu Z, Wang X, Gao S, Pan Y, Galais MP, Zaanan A, Ma Z, Li H, Wang Y, Shen L; ORIENT-15 study group. Lu Z, et al. Among authors: wang x, wang j, wang y, wang b. BMJ. 2022 Apr 19;377:e068714. doi: 10.1136/bmj-2021-068714. BMJ. 2022. PMID: 35440464 Free PMC article. Clinical Trial.

2

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.

Cui Y, Li Q, Yu Y, Chen Y, Feng Y, Wang Y, Liu T. Cui Y, et al. Among authors: wang y. Cancer Chemother Pharmacol. 2013 Jan;71(1):145-52. doi: 10.1007/s00280-012-1991-y. Epub 2012 Oct 12. Cancer Chemother Pharmacol. 2013. PMID: 23064955 Clinical Trial.

3

β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression.

Hu Z, Wu H, Li Y, Hou Q, Wang Y, Li S, Xia B, Wu S. Hu Z, et al. Among authors: wang y. Anticancer Drugs. 2015 Jun;26(5):531-9. doi: 10.1097/CAD.0000000000000216. Anticancer Drugs. 2015. PMID: 25646744

4

Endoplasmic reticulum chaperone glucose-regulated protein 78 in gastric cancer: An emerging biomarker.

Wang Y, Wang JH, Zhang XL, Wang XL, Yang L. Wang Y, et al. Among authors: wang jh, wang xl. Oncol Lett. 2018 May;15(5):6087-6093. doi: 10.3892/ol.2018.8114. Epub 2018 Feb 26. Oncol Lett. 2018. PMID: 29616092 Free PMC article. Review.

5

Routine-Dose and High-Dose Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial.

Li X, Zhang L, Jiang D, Wang Y, Zang A, Ding C, Zhao M, Su W, Zhang Y, Zhong D, Wu J, Zhang C, An G, Hu X, Cheng G, Wang H, Li Y, He X, Liu J, Liang L, Ding L, Mao L, Zhang S. Li X, et al. Among authors: wang h, wang y. Clin Cancer Res. 2020 Jul 1;26(13):3162-3171. doi: 10.1158/1078-0432.CCR-19-3064. Epub 2020 Feb 14. Clin Cancer Res. 2020. PMID: 32060099 Clinical Trial.

6

EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study.

Yang G, Li J, Xu H, Yang Y, Yang L, Xu F, Xia B, Zhu VW, Nagasaka M, Yang Y, Li Y, Qiu W, Ying J, Ou SI, Wang Y. Yang G, et al. Among authors: wang y. Lung Cancer. 2020 Jul;145:186-194. doi: 10.1016/j.lungcan.2020.03.014. Epub 2020 Mar 18. Lung Cancer. 2020. PMID: 32336530

7

Apatinib in combination with pemetrexed-platinum chemotherapy for chemo-naive non-squamous non-small cell lung cancer: a phase II clinical study.

Yang G, Xu H, Yang L, Xu F, Zhang S, Yang Y, Wang Y. Yang G, et al. Among authors: wang y. Lung Cancer. 2020 Sep;147:229-236. doi: 10.1016/j.lungcan.2020.07.024. Epub 2020 Jul 23. Lung Cancer. 2020. PMID: 32739743 Clinical Trial.

8

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients.

Yu S, Wang Y, Cheng X, Lv M, Cui Y, Li W, Yu Y, Li Q, Liu T. Yu S, et al. Among authors: wang y. Cancer Manag Res. 2020 Oct 13;12:10091-10101. doi: 10.2147/CMAR.S270387. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116865 Free PMC article.

9

Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma.

Li W, Li Q, Yu Y, Wang Y, Chen E, Chen L, Wang Z, Cui Y, Liu T. Li W, et al. Among authors: wang z, wang y. Cancer Manag Res. 2020 Nov 2;12:11113-11119. doi: 10.2147/CMAR.S276969. eCollection 2020. Cancer Manag Res. 2020. PMID: 33173344 Free PMC article.

10

Anlotinib combined with gefitinib can significantly improve the proliferation of epidermal growth factor receptor-mutant advanced non-small cell lung cancer in vitro and in vivo.

Li T, Qian Y, Zhang C, Uchino J, Provencio M, Wang Y, Shi X, Zhang Y, Zhang X. Li T, et al. Among authors: wang y. Transl Lung Cancer Res. 2021 Apr;10(4):1873-1888. doi: 10.21037/tlcr-21-192. Transl Lung Cancer Res. 2021. PMID: 34012799 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293,144 results

Search Page

Filters